10.3978/j.issn.1000-9604.2015.12.03
Association between HER2 status and response to neoadjuvant anthracycline followed by paclitaxel plus carboplatin chemotherapy without trastuzumab in breast cancer
27
This study was supported by grants from the National Natural Science Foundation of China81302330, 30973436 and 81071629;the National Key Technology Research and Development Program of the Ministry of Science and Technology of China2014BAI09B08;the 973 project 2013CB911004 and the 985-Ⅲ project
2016-01-22(万方平台首次上网日期,不代表论文的发表时间)
共9页
553-561